5700 healthy subjects
Showing 1 - 25 of >10,000
Healthy Trial in Miami, Philadelphia, Quebec (GLS-5700)
Completed
- Healthy
- GLS-5700
-
Miami, Florida
- +2 more
Jan 5, 2022
Healthy, Zika Trial in San Juan (GLS-5700, Placebo)
Completed
- Healthy
- Zika
- GLS-5700
- Placebo
-
San Juan, Puerto Rico
- +2 more
Jan 5, 2022
Type 2 Diabetes Trial (HRS-7535 Tablets)
Not yet recruiting
- Type 2 Diabetes
- HRS-7535 Tablets
- (no location specified)
Nov 9, 2023
Pharmacokinetic Effect of AstraGin on Whey Protein Absorption and Muscle Function in Healthy Subjects Trial in Taichung
Not yet recruiting
- Pharmacokinetic Effect of AstraGin on Whey Protein Absorption and Muscle Function in Healthy Subjects
- AstraGin (Ginseng and Astragalus Saponin Extract)
- Placebo
-
Taichung, TaiwanChung Shan Medical University
Oct 26, 2023
Healthy Subjects, Obesity, T2DM (Type 2 Diabetes) Trial in Changchun (HEC88473 injection, Placebo)
Completed
- Healthy Subjects
- +2 more
- HEC88473 injection
- Placebo
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Jul 14, 2023
Mass Balance Study in Healthy Subjects Trial ([14C]HLX208)
Not yet recruiting
- Mass Balance Study in Healthy Subjects
- (no location specified)
Apr 24, 2023
Healthy Adult Subjects Trial in San Antonio (TTYP01, Radicava, Radicava ORS)
Recruiting
- Healthy Adult Subjects
- TTYP01
- +2 more
-
San Antonio, TexasICON Early Phase Services
Oct 24, 2023
Healthy Subjects Trial in Shanghai (JYP0061, )
Completed
- Healthy Subjects
- JYP0061
- placebo
-
Shanghai, Shanghai, ChinaShanghai Xuhui District Central Hospital
Nov 16, 2023
Healthy Subjects Trial in Melbourne (ISM5411, Placebo)
Not yet recruiting
- Healthy Subjects
- ISM5411
- Placebo
-
Melbourne, Victoria, AustraliaNucleus Network
Aug 22, 2023
Healthy Trial in Beijing (STSA-1201 Subcutaneous injection, Placebo)
Recruiting
- Healthy
- STSA-1201 Subcutaneous injection
- Placebo
-
Beijing, Beijing, ChinaBeijing Shijitan Hospital, Capital Medical University
Aug 10, 2023
Healthy Male Subjects Trial (Recombinant Humanized Anti-PD-1 Monoclonal Antibody Solution for Injection, Pembrolizumab
Not yet recruiting
- Healthy Male Subjects
- Recombinant Humanized Anti-PD-1 Monoclonal Antibody Solution for Injection
- Pembrolizumab injection
- (no location specified)
Oct 30, 2023
Healthy Volunteers Trial in Nedlands (VG290131)
Recruiting
- Healthy Volunteers
-
Nedlands, Western Australia, AustraliaLinear Clinical Research Ltd
Oct 17, 2023
Transcranial Direct Current Stimulation, Motor Evoked Potential, Healthy Subjects Trial in Shijiazhuang (toDCS 2mA 1Hz, toDCS
Recruiting
- Transcranial Direct Current Stimulation
- +2 more
- toDCS 2mA 1Hz
- +3 more
-
Shijiazhuang, Hebei, Chinathe First Hospital of Hebei Medical University
Oct 7, 2023
Healthy Male Subjects Trial in Shanghai ([14C] Yiqibuvir)
Not yet recruiting
- Healthy Male Subjects
- [14C] Yiqibuvir
-
Shanghai, Shanghai, ChinaShanghai xuhui central hospital
Aug 16, 2023
Healthy Trial (Test (T) Bilastine, Reference (R) Bilastine)
Not yet recruiting
- Healthy
- Test (T) Bilastine
- Reference (R) Bilastine
- (no location specified)
Oct 19, 2023
Primary Biliary Cholangitis Trial in Suzhou ([14C]CS0159)
Not yet recruiting
- Primary Biliary Cholangitis
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Oct 18, 2023
Pharmacokinetic Trial in Changchun (Lanifibranor)
Active, not recruiting
- Pharmacokinetic
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Nov 13, 2023
Pneumococcal Disease Trial (XJ103 Injection, Placebo)
Not yet recruiting
- Pneumococcal Disease
- XJ103 Injection
- Placebo
- (no location specified)
Sep 6, 2023
The Effects of Clarithromycin or Cyclosporine on Pharmacokinetics of Deuterium Hydrobromide Ramidvir Tablets in Healthy Chinese
Active, not recruiting
- The Effects of Clarithromycin or Cyclosporine on Pharmacokinetics of Deuterium Hydrobromide Ramidvir Tablets in Healthy Chinese Subjects
- Mindeudesivir hydrobromide tablets and Clarithromycin tablets
- Mindeudesivir hydrobromide tablets and Cyclosporine softgels
-
Zhengzhou, Henan, ChinaZhengzhou Sixth People's Hospital
Aug 15, 2023